DI CHIARA, COSTANZA
 Distribuzione geografica
Continente #
NA - Nord America 1.128
AS - Asia 1.075
EU - Europa 856
AF - Africa 332
SA - Sud America 274
OC - Oceania 35
Continente sconosciuto - Info sul continente non disponibili 13
Totale 3.713
Nazione #
US - Stati Uniti d'America 967
SG - Singapore 404
IT - Italia 208
BR - Brasile 178
CN - Cina 169
HK - Hong Kong 107
DE - Germania 103
PL - Polonia 68
FI - Finlandia 47
VN - Vietnam 44
RU - Federazione Russa 36
IN - India 34
GB - Regno Unito 30
NL - Olanda 30
FR - Francia 27
CA - Canada 26
AT - Austria 25
TR - Turchia 24
SE - Svezia 21
ZA - Sudafrica 19
AR - Argentina 18
IQ - Iraq 18
EC - Ecuador 16
BJ - Benin 15
ES - Italia 15
JP - Giappone 15
KR - Corea 15
CH - Svizzera 14
IE - Irlanda 14
UZ - Uzbekistan 14
MA - Marocco 13
MX - Messico 13
TH - Thailandia 13
AZ - Azerbaigian 12
CO - Colombia 12
GH - Ghana 12
MK - Macedonia 12
ML - Mali 12
RO - Romania 12
AD - Andorra 11
AE - Emirati Arabi Uniti 11
GR - Grecia 11
HR - Croazia 11
ID - Indonesia 11
IR - Iran 11
JM - Giamaica 11
KH - Cambogia 11
KZ - Kazakistan 11
NG - Nigeria 11
PY - Paraguay 11
TN - Tunisia 11
VE - Venezuela 11
AL - Albania 10
AO - Angola 10
BA - Bosnia-Erzegovina 10
BF - Burkina Faso 10
BW - Botswana 10
BY - Bielorussia 10
CZ - Repubblica Ceca 10
EG - Egitto 10
KG - Kirghizistan 10
PS - Palestinian Territory 10
PT - Portogallo 10
SA - Arabia Saudita 10
TJ - Tagikistan 10
UA - Ucraina 10
AM - Armenia 9
CR - Costa Rica 9
CU - Cuba 9
DJ - Gibuti 9
DK - Danimarca 9
GA - Gabon 9
IS - Islanda 9
LU - Lussemburgo 9
LY - Libia 9
ME - Montenegro 9
MG - Madagascar 9
MN - Mongolia 9
NO - Norvegia 9
UG - Uganda 9
BZ - Belize 8
CG - Congo 8
CW - ???statistics.table.value.countryCode.CW??? 8
DZ - Algeria 8
EE - Estonia 8
GF - Guiana Francese 8
GM - Gambi 8
IL - Israele 8
LB - Libano 8
LV - Lettonia 8
MY - Malesia 8
NC - Nuova Caledonia 8
NP - Nepal 8
PE - Perù 8
PK - Pakistan 8
TT - Trinidad e Tobago 8
ZM - Zambia 8
ZW - Zimbabwe 8
AU - Australia 7
CM - Camerun 7
Totale 3.399
Città #
Singapore 234
Ashburn 190
Hong Kong 99
Chandler 97
Santa Clara 81
Munich 62
Beijing 54
Bytom 51
Milan 43
Los Angeles 42
Fairfield 34
Boardman 33
Hefei 24
São Paulo 21
Chicago 18
Ho Chi Minh City 18
Padova 17
Buffalo 16
Lappeenranta 16
Nuremberg 16
Toronto 16
Cambridge 15
Cotonou 15
Helsinki 15
New York 15
Houston 13
Turku 13
Warsaw 13
Baku 12
Bamako 12
Hanoi 12
Seattle 12
Tashkent 12
Vienna 12
Andorra la Vella 11
Dublin 11
Medford 11
Princeton 11
Salt Lake City 11
Johannesburg 10
Phnom Penh 10
Rome 10
Seoul 10
Wilmington 10
Accra 9
Antananarivo 9
Bishkek 9
Dushanbe 9
Kampala 9
Lagos 9
Libreville 9
Luanda 9
Padua 9
Athens 8
Baghdad 8
Djibouti 8
Frankfurt am Main 8
Gaborone 8
Guayaquil 8
Istanbul 8
Kingston 8
Lusaka 8
Redondo Beach 8
Reykjavik 8
Riga 8
San Diego 8
San José 8
Woodbridge 8
Yerevan 8
Addis Ababa 7
Cairo 7
Castries 7
Conakry 7
Düsseldorf 7
Harare 7
Hyderabad 7
London 7
Managua 7
Minsk 7
Noumea 7
Podgorica 7
Pune 7
Roxbury 7
Skopje 7
Tokyo 7
Turin 7
Ulan Bator 7
Willemstad 7
Amman 6
Brooklyn 6
Caracas 6
Cayenne 6
Curitiba 6
Douala 6
Kigali 6
Nassau 6
Nouakchott 6
San Francisco 6
Tallinn 6
Verona 6
Totale 1.872
Nome #
Mild SARS-CoV-2 Infections and Neutralizing Antibody Titers 159
Epidemiologic, Clinical, and Immunological Characteristics of SARS-CoV-2 Infection and COVID-19 Vaccination in the Pediatric Population 155
Treatment for Severe Malaria: Post-Artesunate Delayed Haemolysis and Neutropenia 144
Antibiotic Prescription Patterns in the Paediatric Primary Care Setting before and after the COVID-19 Pandemic in Italy: An Analysis Using the AWaRe Metrics 142
Asymptomatic and Mild SARS-CoV-2 Infections Elicit Lower Immune Activation and Higher Specific Neutralizing Antibodies in Children Than in Adults 133
Protective SARS-CoV-2 Antibody Response in Children With Inflammatory Bowel Disease 132
Analytical and clinical performances of a SARS-CoV-2 S-RBD IgG assay: Comparison with neutralization titers 130
Alternative Antimicrobial Irrigation Strategies for the Treatment of Infections in Children: A Review of the Existing Literature 127
Antibiotic prescribing patterns in paediatric primary care in italy: Findings from 2012–2018 123
Daptomycin for Treatment of S. epidermidis Endocarditis in an Extremely Preterm Neonate—Outcome and Perspectives 119
Mid- and Long-Term Atrio-Ventricular Functional Changes in Children after Recovery from COVID-19 117
Long-term Immune Response to SARS-CoV-2 Infection Among Children and Adults After Mild Infection 114
Early Use of Sotrovimab in Children: A Case Report of an 11-Year-Old Kidney Transplant Recipient Infected with SARS-CoV-2 114
SARS-CoV-2 seroprevalence and associated factors, based on HIV serostatus, in young people in Sofala province, Mozambique 112
Left ventricular longitudinal strain alterations in asymptomatic or mildly symptomatic paediatric patients with SARS-CoV-2 infection 110
Therapeutic Options and Outcomes for the Treatment of Children with Gram-Positive Bacteria with Resistances of Concern: A Systematic Review 108
Multi-drug-resistant infections in the COVID-19 era: a framework for considering the potential impact 107
Stronger and durable SARS-CoV-2 immune response to mRNA vaccines in 5–11 years old children with prior COVID-19 105
Early Treatments of Fragile Children with COVID-19-Results of CLEVER (Children COVID Early Treatment), a Retrospective, Observational Study 104
A silent strain: the unseen burden of acute respiratory infections in children 101
Clinical features of COVID-19 in Italian outpatient children and adolescents during Parental, Delta, and Omicron waves: a prospective, observational, cohort study 97
Correction to: Left ventricle longitudinal strain alterations in asymptomatic or mildly symptomatic pediatric patients with recent SARS-CoV-2 infection 96
Preliminary Evidence on Pulmonary Function after Asymptomatic and Mild COVID-19 in Children 95
Cardiac Function Evaluation after SARS-CoV-2 mRNA Vaccination in Children and Adolescents: A Prospective Speckle-Tracking Echocardiography Study 94
Clinical and Analytical Performance of ELISA Salivary Serologic Assay to Detect SARS-CoV-2 IgG in Children and Adults 93
Risk of SARS-CoV-2 Reinfection in Children Within the 12 Months Following Mild COVID-19: Insights From a Survey Study 91
Real-world effectiveness of influenza vaccination in preventing influenza and influenza-like illness in children 89
Long-term neuropsychiatric and neuropsychological impact of the pandemic in Italian COVID-19 family clusters, including children and parents 89
Impact of Prior SARS-CoV-2 Infection on COVID-19 Vaccine Effectiveness in Children and Adolescents in Norway and Italy 80
Comparative study showed that children faced a 78% higher risk of new-onset conditions after they had COVID-19 80
Perceived Psychological Impact on Children and Parents of Experiencing COVID-19 Infection in One or More Family Members 72
Exploring different modelling approaches to forecast the community acute respiratory infections burden in children: an Italian epidemiological time series study 70
Mid- and long-term atrio-ventricular mechanics in children after recovery from asymptomatic or mildly symptomatic SARS-CoV-2 infection 69
MID AND LONG TERM ATRIO-VENTRICULAR MECHANISM IN CHILDREN AFTER RECOVERY FROM ASYMPTOMATIC O MILDLY SYMPTOMATIC SARS COV2 INFECTION 62
COVID-19 in Infants Less than 3 Months: Severe or Not Severe Disease? 50
Revisiting antimicrobial stewardship in the paediatric intensive care unit: insights from an unconventional approach 46
Clinical characteristics of COVID-19 in children and adolescents: insights from an Italian paediatric cohort using a machine-learning approach 25
Totale 3.754
Categoria #
all - tutte 13.301
article - articoli 12.988
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26.289


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202137 0 0 0 0 0 0 21 0 4 2 0 10
2021/2022144 8 2 8 4 2 28 6 4 15 6 19 42
2022/2023164 26 26 8 18 31 15 3 13 16 2 4 2
2023/2024223 2 22 35 9 15 32 32 16 9 6 26 19
2024/20251.148 7 75 47 51 116 47 59 87 65 96 177 321
2025/20262.038 296 282 653 685 122 0 0 0 0 0 0 0
Totale 3.754